FI943120A - Alfa-substituoituja bentseenimetanamiinijohdannaisia - Google Patents

Alfa-substituoituja bentseenimetanamiinijohdannaisia Download PDF

Info

Publication number
FI943120A
FI943120A FI943120A FI943120A FI943120A FI 943120 A FI943120 A FI 943120A FI 943120 A FI943120 A FI 943120A FI 943120 A FI943120 A FI 943120A FI 943120 A FI943120 A FI 943120A
Authority
FI
Finland
Prior art keywords
alpha
substituted benzene
benzene methanamine
methanamine derivatives
derivatives
Prior art date
Application number
FI943120A
Other languages
English (en)
Swedish (sv)
Other versions
FI943120A0 (fi
Inventor
Marcel August Constant Janssen
Daele Georges Henri Paul Van
Jean-Paul Rene Marie A Bosmans
Den Keybus Frans Maria Alf Van
Karin Josepha Malvina M Nuyens
Paul Adriaan Jan Janssen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI943120A0 publication Critical patent/FI943120A0/fi
Publication of FI943120A publication Critical patent/FI943120A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/40Nitrogen atoms attached in position 8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60N-oxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI943120A 1991-12-30 1994-06-29 Alfa-substituoituja bentseenimetanamiinijohdannaisia FI943120A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91203430 1991-12-30
PCT/EP1992/002995 WO1993013052A1 (en) 1991-12-30 1992-12-22 α-SUBSTITUTED BENZENEMETHANAMINE DERIVATIVES

Publications (2)

Publication Number Publication Date
FI943120A0 FI943120A0 (fi) 1994-06-29
FI943120A true FI943120A (fi) 1994-06-29

Family

ID=8208118

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943120A FI943120A (fi) 1991-12-30 1994-06-29 Alfa-substituoituja bentseenimetanamiinijohdannaisia

Country Status (17)

Country Link
US (2) US5407961A (fi)
EP (1) EP0620809B1 (fi)
JP (1) JPH07502524A (fi)
CN (1) CN1033451C (fi)
AP (1) AP406A (fi)
AT (1) ATE149484T1 (fi)
AU (1) AU664874B2 (fi)
CA (1) CA2125676A1 (fi)
DE (1) DE69217992T2 (fi)
FI (1) FI943120A (fi)
HU (1) HUT67030A (fi)
IL (1) IL104258A (fi)
MX (1) MX9207620A (fi)
NO (1) NO942481L (fi)
TW (1) TW249227B (fi)
WO (1) WO1993013052A1 (fi)
ZA (1) ZA9210079B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE75693B1 (en) * 1990-07-10 1997-09-10 Janssen Pharmaceutica Nv HIV-inhibiting benzeneacetamide derivatives
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5767310A (en) * 1993-03-19 1998-06-16 Merck & Co., Inc. Phenoxyphenylacetic acid derivatives
US5686478A (en) * 1993-07-20 1997-11-11 Merck & Co. Inc. Endothelin antagonists
US5559135A (en) * 1994-09-14 1996-09-24 Merck & Co., Inc. Endothelin antagonists bearing pyridyl amides
US5538991A (en) * 1994-09-14 1996-07-23 Merck & Co., Inc. Endothelin antagonists bearing 5-membered heterocyclic amides
CZ290670B6 (cs) 1994-10-21 2002-09-11 Nps Pharmaceuticals, Inc. Sloučeniny modulující receptory anorganických iontů a farmaceutický prostředek, který je obsahuje
PT907631E (pt) * 1996-05-01 2003-10-31 Nps Pharma Inc Compostos inorganicos activos como receptores de ioes
DE69932820T4 (de) * 1998-06-19 2008-06-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thiolester und ihre anwendungen
JP4480890B2 (ja) 1998-08-13 2010-06-16 バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト アシル化アミノフェニルスルホニル尿素を有する除草剤組成物
EP2280601A4 (en) * 2008-02-21 2012-08-29 Sequoia Pharmaceuticals Inc AMINO ACID HEMMER OF CYTOCHROM P450

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246429A (en) * 1978-06-23 1981-01-20 Janssen Pharmaceutica, N.V. Novel α-amino-phenylacetic acid derivatives
IT1226300B (it) * 1988-07-26 1990-12-27 Zambon Spa Processo per la preparazione di intermedi per la sintesi del diltiazem.
IE75693B1 (en) * 1990-07-10 1997-09-10 Janssen Pharmaceutica Nv HIV-inhibiting benzeneacetamide derivatives

Also Published As

Publication number Publication date
CN1073936A (zh) 1993-07-07
DE69217992D1 (de) 1997-04-10
EP0620809B1 (en) 1997-03-05
FI943120A0 (fi) 1994-06-29
NO942481D0 (fi) 1994-06-30
TW249227B (fi) 1995-06-11
HU9401381D0 (en) 1994-08-29
AP406A (en) 1995-09-22
DE69217992T2 (de) 1997-06-12
CA2125676A1 (en) 1993-07-08
MX9207620A (es) 1993-06-01
IL104258A0 (en) 1993-05-13
US5407961A (en) 1995-04-18
WO1993013052A1 (en) 1993-07-08
ZA9210079B (en) 1994-06-29
ATE149484T1 (de) 1997-03-15
CN1033451C (zh) 1996-12-04
AP9200469A0 (en) 1993-01-31
JPH07502524A (ja) 1995-03-16
US5480912A (en) 1996-01-02
AU664874B2 (en) 1995-12-07
NO942481L (fi) 1994-06-30
HUT67030A (en) 1995-01-30
EP0620809A1 (en) 1994-10-26
IL104258A (en) 1997-04-15
AU3258193A (en) 1993-07-28

Similar Documents

Publication Publication Date Title
MX9205145A (es) Nuevos derivados heterociclicos.
DE69208877D1 (de) Chinuclidinderivate
NO922182D0 (no) Krystallinske oksatiolan-derivater
DE58901003D1 (de) Didehydro-vitamin d3-derivate.
ES2012451B3 (es) Derivados de benceno sustituidos.
FI925763A (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
LV10086A (lv) CIV - inhibejosi benzolacetamida atvasinajumi
NO930156D0 (no) Nye oksazolylderivater
ATE149484T1 (de) Alpha-substituierte benzenmethanamin-derivate
MX9205003A (es) Derivados novedosos de benzopirano.
DK615186D0 (da) Substituerede 5,6-dialkoxyquinazolinderivater
FI925469A (fi) Tiazolylsubstituerade kinolylymetoxifenylaettiksyraderivat
MX9204370A (es) Derivados de pirazol.
MX9206710A (es) Derivados de piridinol
MX9201931A (es) Nuevos derivados de tiazol.
MX9205973A (es) Derivados de benzo-isoquinolinas.
FI922980A (fi) 2-piperidinylpyrimidin-4-karboxamidderivat, framstaellning av dessa ochterapeutisk anvaendning av dessa
FI923697A (fi) Kondenserat pyrimidinderivat
NO892714L (no) Substituerte azacykloheksylderivater.
KR930702353A (ko) 2- 카르바페넴 유도체
FI922443A0 (fi) Framstaellning av 6-0-alkylelsamicin-a -derivat.
NO303283B1 (no) Substituerte benzenderivater
MX9202291A (es) Derivados carboxamido-(3,2n)-carbociclico-2-amino tetralinas.
FI941681A0 (fi) Tioformamidijohdannaiset
DE69227554D1 (de) Indolinospirobenzopyran-derivate

Legal Events

Date Code Title Description
FD Application lapsed